Infliximab, License Holder Unspecified

CHEBI:CHEBI_753776

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
marketing_start_date
20170701
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
active_ingredient_name
INFLIXIMAB
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Patheon Italia S.p.A.
active_ingredient_strength
100 mg/10mL
package_marketing_start_date
01-JUL-17
generic_name
Infliximab, License Holder Unspecified
product_ndc
68225-088
spl_id
bc2b34cd-9497-457e-bf0f-86bca1a32c86
package_ndc
68225-088-00
package_description
90 TRAY in 1 CONTAINER (68225-088-00) / 98 VIAL in 1 TRAY / 20 mL in 1 VIAL
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class